Status: current, Defined. Date: 31-Jul 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3961731000168113 | Bosentan (GH) (bosentan 125 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3961741000168116 | Bosentan (GH) 125 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bosentan (GH) 125 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Bosentan (GH) 125 mg tablet | Is a | bosentan 125 mg tablet | true | Inferred relationship | Some | ||
| Bosentan (GH) 125 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Bosentan (GH) 125 mg tablet | Is a | Bosentan (GH) | true | Inferred relationship | Some | ||
| Bosentan (GH) 125 mg tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Bosentan (GH) 125 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 2011171609 | |
| Bosentan (GH) 125 mg tablet | has intended active ingredient | bosentan | true | Inferred relationship | Some | 2011171608 | |
| Bosentan (GH) 125 mg tablet | has Australian BoSS | bosentan | true | Inferred relationship | Some | 2011171608 |
Reference Sets
Trade product unit of use reference set
FHIR